Pfizer and Moderna could make billions of dollars from COVID-19 booster shots, earnings comparable to the $6 billion generated each year in flu vaccine sales....
Moderna and IBM are joining forces to collaborate on strengthening and improving COVID-19 vaccination management, the companies announced on Thursday (March 4). The collaboration will...
The United States is now in what is considered to be the second wave of the COVID-19 pandemic. And while the number of cases and...
Dr. Moncef Slaoui, who acts as President Donald Trump’s COVID-19 vaccine czar, said the U.S. should have enough vaccines to immunize 100 million people by...
As the first approved coronavirus vaccine arrives in the U.K. this week, the next phase of the fight to contain the deadly virus will fall...
With COVID-19’s worldwide case count officially exceeding 11 million and waves of closures sweeping U.S. states in an attempt to stifle the resurgent threat, an...
A COVID-19 vaccine being developed by the Cambridge, Massachusetts firm Moderna is showing early signs of promise, with an early-stage human trial showing some compelling results. This...